|
End-of-day quote
Shanghai S.E.
08/10/2026
|
5-day change | 1st Jan Change | ||
| 5.060 CNY | +0.20% |
|
+0.20% | -1.17% |
| 09-01 | Jointown Pharmaceutical Seeks Up to 2.8 Billion Yuan via Private Placement | MT |
| 08-28 | Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.8 billion in funding | CI |
Company Valuation: Jointown Pharmaceutical Group Co., Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,919 | 24,052 | 26,691 | 25,148 | 25,531 | 25,231 | - | - |
| Change | - | -10.65% | 10.97% | -5.78% | 1.52% | -1.17% | - | - |
| Enterprise Value (EV) 1 | 29,021 | 21,882 | 24,319 | 20,414 | 20,954 | 21,107 | 20,467 | 20,936 |
| Change | - | -24.6% | 11.14% | -16.06% | 2.65% | 0.73% | -3.03% | 2.29% |
| P/E | 11.6x | 12.2x | 12.7x | 10.2x | 11.6x | 11.1x | 10.2x | 9.22x |
| PBR | 1.31x | 1.09x | 1.14x | 0.95x | 0.96x | 0.86x | 0.82x | 0.78x |
| PEG | - | -0.8x | 1.76x | 0.6x | -1x | 2.77x | 1.21x | 0.9x |
| Capitalization / Revenue | 0.22x | 0.17x | 0.18x | 0.17x | 0.16x | 0.15x | 0.14x | 0.13x |
| EV / Revenue | 0.24x | 0.16x | 0.16x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x |
| EV / EBITDA | 6.93x | 6.21x | 6.5x | 4.61x | 5.18x | 4.42x | 3.79x | 3.45x |
| EV / EBIT | 8.08x | 7.67x | 8.05x | 5.62x | 6.34x | 6.01x | 5.35x | 4.9x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2 | 0.203 | 0.219 | 0.248 |
| Rate of return | 2.04% | 3.83% | 3.57% | 3.91% | 3.91% | 4.01% | 4.33% | 4.9% |
| EPS 2 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.44 | 0.4576 | 0.4961 | 0.5489 |
| Distribution rate | 23.6% | 46.7% | 45.5% | 40% | 45.5% | 44.4% | 44.2% | 45.2% |
| Net sales 1 | 122,407 | 140,424 | 150,140 | 151,810 | 161,390 | 171,813 | 182,137 | 192,315 |
| EBITDA 1 | 4,187 | 3,526 | 3,741 | 4,427 | 4,046 | 4,777 | 5,398 | 6,073 |
| EBIT 1 | 3,593 | 2,853 | 3,023 | 3,635 | 3,306 | 3,513 | 3,824 | 4,274 |
| Net income 1 | 2,448 | 2,085 | 2,174 | 2,507 | 2,255 | 2,300 | 2,507 | 2,762 |
| Net Debt 1 | 2,102 | -2,170 | -2,372 | -4,734 | -4,576 | -4,125 | -4,765 | -4,296 |
| Reference price 2 | 5.470 | 4.846 | 5.434 | 5.120 | 5.120 | 5.060 | 5.060 | 5.060 |
| Nbr of stocks (in thousands) | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | 4,986,434 | - | - |
| Announcement Date | 4/25/22 A | 4/24/23 A | 4/26/24 A | 4/28/25 A | 4/27/26 A | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.04x | 0.12x | 4.41x | 4.02% | 3.76B | ||
| 33.76x | 12.26x | 24.76x | 0.58% | 1,060B | ||
| 28.75x | 6.35x | 18.21x | 2.07% | 623B | ||
| 34.38x | 7.99x | 16.52x | 2.56% | 480B | ||
| 103.88x | 5.82x | 24.82x | 2.39% | 352B | ||
| 19.43x | 4.75x | 11.8x | 2.78% | 345B | ||
| 20.28x | 5.28x | 13.08x | 3.01% | 274B | ||
| 20.79x | 4.27x | 12.2x | 2.08% | 249B | ||
| 26.09x | 6.8x | 12.11x | 2.44% | 223B | ||
| -44.42x | 6.54x | 25.48x | 2.24% | 182B | ||
| Average | 25.40x | 6.02x | 16.34x | 2.42% | 379.18B | |
| Weighted average by Cap. | 32.17x | 7.83x | 19.07x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600998 Stock
- Valuation Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions
















